Evidence map›Paper›PMID 40536013›Full record

ReviewChemMedChem2025

The Role of Five-Membered Aromatic Rings Containing N and O in Modulating Bile Acid Receptors: An Overview.

Claudia Finamore, Carmen Festa, Rosa Barbato, Stefano Fiorucci, Angela Zampella, Simona De Marino

Abstract readReview
In one paragraph

Review in ChemMedChem, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Probing Weak Halogen Bonding in Aqueous Solution.Journal of the American Chemical Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Claudia FinamoreDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, Naples, 80131, Italy.ORCID https://orcid.org/0000-0003-3064-0415
Carmen FestaDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, Naples, 80131, Italy.ORCID https://orcid.org/0000-0001-8879-4332
Rosa BarbatoDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, Naples, 80131, Italy.
Stefano FiorucciDepartment of Medicine and Surgery, University of Perugia, Piazza L. Severi, 1, Perugia, 06132, Italy.
Angela ZampellaDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, Naples, 80131, Italy.
Simona De MarinoDepartment of Pharmacy, University of Naples Federico II, Via Domenico Montesano 49, Naples, 80131, Italy.ORCID https://orcid.org/0000-0002-0300-5048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the past decades, extensive scientific research in the fields of chemistry and pharmaceutical chemistry has led to the synthesis and study of numerous chemical compounds with diverse therapeutic applications. Many of these compounds feature heterocyclic aromatic structures, including four-, five-, and six-membered rings. Among them, five-membered heteroaromatic rings have garnered particular attention in medicinal chemistry due to their favorable properties, such as enhanced metabolic stability, solubility, and bioavailability, key attributes for the development of effective drugs. The distinctive physicochemical properties and biological activities of five-membered heterocycles have established them as vital structural motifs in numerous clinically effective drugs. These heterocyclic compounds play a crucial role in the design of therapeutic agents, including those targeting bile acid receptors. Bile acid receptor modulators, activated by endogenous bile acids, offer promising potential in treating a variety of metabolic and enterohepatic disorders, such as dyslipidemia, diabetes, cholestasis, and inflammatory bowel disease. This review aims to provide an up-to-date overview of aromatic five-membered nitrogen- and oxygen-containing heterocycles, focusing on their role as bile acid receptor modulators, particularly farnesoid X receptor and G protein-coupled bile acid receptor 1. These receptors are clinically validated targets for the treatment of metabolic disorders and nonalcoholic steatohepatitis.

Indexed as

Heterocyclic CompoundsNitrogenAnimalsBile Acids and SaltsHumansMolecular StructureBile Acids and SaltsHeterocyclic CompoundsNitrogenfarnesoid X receptorsfive‐membered ringsG protein‐coupled bile acid receptors 1heterocyclic compoundsisoxazole

Identifiers

PMID40536013
PMCPMC12368480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.